Open Access. Powered by Scholars. Published by Universities.®
Endocrinology, Diabetes, and Metabolism Commons™
Open Access. Powered by Scholars. Published by Universities.®
- Keyword
Articles 1 - 3 of 3
Full-Text Articles in Endocrinology, Diabetes, and Metabolism
Chronic Glp1 Therapy Reduces Postprandial Il6 In Obese Humans With Prediabetes, Vala Hamidi, Hongyu Wang, Vi Pham, Karla Bermudez Saint Andre, Heinrich Taegtmeyer, Absalon D Gutierrez
Chronic Glp1 Therapy Reduces Postprandial Il6 In Obese Humans With Prediabetes, Vala Hamidi, Hongyu Wang, Vi Pham, Karla Bermudez Saint Andre, Heinrich Taegtmeyer, Absalon D Gutierrez
Journal Articles
Single-dose glucagon-like peptide 1 (GLP1) therapy increases postprandial plasma IL6 levels in prediabetic, obese humans. GLP1-IL6 interactions underly multiple antidiabetic effects, but these may differ after acute versus chronic therapy. This study examines postprandial effects of GLP1 after chronic therapy. Seven humans (six Black) with prediabetes and obesity completed 6 weeks of exenatide extended release therapy. Then subjects returned for pre- and post-meal measurements of plasma IL6, GLP1, glucagon, and related inflammatory markers. Weight, which was measured before and after therapy, did not change. Plasma IL6 decreased from baseline to postmeal state ( = 0.016), with decreases in free fatty …
Cardiometabolic Health: Actionable Prevention Strategies And New Care Models, Omar Leonards, David Aguilar
Cardiometabolic Health: Actionable Prevention Strategies And New Care Models, Omar Leonards, David Aguilar
The Texas Heart Institute Journal
No abstract provided.
Cardiometabolic Health: Actionable Prevention Strategies And New Care Models, Omar Leonards, David Aguilar
Cardiometabolic Health: Actionable Prevention Strategies And New Care Models, Omar Leonards, David Aguilar
School of Medicine Faculty Publications
No abstract provided.